HELIOS Klinikum Berlin-Buch — Berlin

Public research footprint of HELIOS Klinikum Berlin-Buch, compiled from the ClinicalTrials.gov public registry.

162

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Breast Neoplasms · Follicular Lymphoma (FL) Grade 3B · Metastatic Cancer

Recently updated registry entries

NCT03725007 — A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in… (Active Not Recruiting)
NCT06841354 — A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination… (Recruiting)
NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at HELIOS Klinikum Berlin-Buch?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.